We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.93B
AUM Growth
+$1.14B
Cap. Flow
+$1.03B
Cap. Flow %
35.37%
Top 10 Hldgs %
55.12%
Holding
624
New
176
Increased
136
Reduced
111
Closed
159

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$172M
2
MU icon
Micron Technology
MU
+$158M
3
AMD icon
Advanced Micro Devices
AMD
+$121M
4
C icon
Citigroup
C
+$119M
5
TSLA icon
Tesla
TSLA
+$105M

Sector Composition

Rank Sector Weight
1 Technology 42.28%
2 Financials 13.02%
3 Consumer Discretionary 12.26%
4 Energy 4.52%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
326
Automatic Data Processing
ADP
$108B
$567K 0.02%
2,376
-6,572
-73% -$1.61M
FATE icon
327
Fate Therapeutics
FATE
$326M
$567K 0.02%
172,863
-117,324
-40% -$514K
CRC icon
328
California Resources
CRC
$4.62B
$562K 0.02%
+10,555
New +$538K
GIII icon
329
G-III Apparel Group
GIII
$1.5B
$559K 0.02%
20,645
-13,906
-40% -$390K
NYT icon
330
New York Times
NYT
$10.2B
$534K 0.02%
+10,427
New +$490K
VIR icon
331
Vir Biotechnology
VIR
$1.49B
$531K 0.02%
+59,625
New +$572K
VZ icon
332
Verizon
VZ
$196B
$529K 0.02%
12,829
-4,741
-27% -$191K
AX icon
333
Axos Financial
AX
$5.68B
$523K 0.02%
9,153
-7,422
-45% -$404K
CVE icon
334
Cenovus Energy
CVE
$52.1B
$515K 0.02%
26,189
-19,511
-43% -$395K
NUS icon
335
Nu Skin
NUS
$267M
$515K 0.02%
48,842
+29,718
+155% +$377K
AGR
336
DELISTED
Avangrid, Inc.
AGR
$507K 0.02%
+14,260
New +$514K
AMAT icon
337
Applied Materials
AMAT
$428B
$503K 0.02%
2,133
GVA icon
338
Granite Construction
GVA
$5.62B
$503K 0.02%
+8,113
New +$481K
ACCO icon
339
Acco Brands
ACCO
$407M
$502K 0.02%
106,785
-43,330
-29% -$216K
CARG icon
340
CarGurus
CARG
$3.47B
$498K 0.02%
+19,017
New +$452K
BKE icon
341
Buckle
BKE
$2.37B
$497K 0.02%
13,463
-6,496
-33% -$243K
FLGT icon
342
Fulgent Genetics
FLGT
$527M
$492K 0.02%
+25,095
New +$524K
HTT
343
High Templar Tech Ltd
HTT
$391M
$488K 0.02%
246,522
BHE icon
344
Benchmark Electronics
BHE
$2.96B
$488K 0.02%
12,358
+3,311
+37% +$122K
FAF icon
345
First American
FAF
$7.58B
$487K 0.02%
+9,034
New +$502K
DEI icon
346
Douglas Emmett
DEI
$1.96B
$486K 0.02%
36,514
-33,729
-48% -$457K
TEVA icon
347
Teva Pharmaceuticals
TEVA
$41.2B
$483K 0.02%
+29,707
New +$458K
CMG icon
348
Chipotle Mexican Grill
CMG
$41.5B
$479K 0.02%
+7,650
New +$475K
FTV icon
349
Fortive
FTV
$18.6B
$465K 0.02%
+8,322
New +$483K
ALKT icon
350
Alkami Technology
ALKT
$2.11B
$448K 0.02%
+15,733
New +$406K

Similar funds

Caxton Associates (New York)'s Q2 2024 Portfolio in Review

As of Q2 2024, Caxton Associates (New York) held 624 positions worth $2.93B, up 64% from $1.78B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Caxton Associates (New York) deployed $1.03B of net new capital in Q2 2024, opening 176 new positions and adding to 136 existing holdings. Its largest new stake was Intel: 5,250,000 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $49.3M trimmed.

  • Caxton Associates (New York)'s largest Q2 2024 buy was Intel: 5,250,000 shares worth $163M.
  • Caxton Associates (New York) added most to Micron Technology in Q2 2024, an estimated $158M increase.
  • Caxton Associates (New York)'s biggest Q2 2024 reduction was Broadcom, cutting an estimated $49.3M.
  • Caxton Associates (New York) fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $50.3M.
  • Caxton Associates (New York)'s ten largest holdings make up 55% of its $2.93B portfolio in Q2 2024.
  • Caxton Associates (New York) opened 176 new positions and closed 159 in Q2 2024.
  • Caxton Associates (New York)'s portfolio value rose 64% quarter-over-quarter to $2.93B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.